These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19519344)

  • 1. A review of the pharmacological interactions of ivermectin in several animal species.
    González-Canga A; Fernández-Martínez N; Sahagún-Prieto A; Diez-Liébana MJ; Sierra-Vega M; García-Vieitez JJ
    Curr Drug Metab; 2009 May; 10(4):359-68. PubMed ID: 19519344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics and metabolism of ivermectin in domestic animal species.
    González Canga A; Sahagún Prieto AM; José Diez Liébana M; Martínez NF; Vega MS; Vieitez JJ
    Vet J; 2009 Jan; 179(1):25-37. PubMed ID: 17851096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics and antiparasitic activity of ivermectin in Hutsul and Toric horses.
    Vyniarska A; Ziółkowski H; Madej-Śmiechowska H; Jaroszewski JJ
    J Vet Pharmacol Ther; 2021 Jan; 44(1):11-17. PubMed ID: 33103252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons from the History of Ivermectin and Other Antiparasitic Agents.
    Campbell WC
    Annu Rev Anim Biosci; 2016; 4():1-14. PubMed ID: 26515271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avermectin use in aquaculture.
    Horsberg TE
    Curr Pharm Biotechnol; 2012 May; 13(6):1095-102. PubMed ID: 22039799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of a liposomal formulation of ivermectin in rabbit after a single subcutaneous administration.
    Bassissi F; Lespine A; Alvinerie M
    Parasitol Res; 2006 Feb; 98(3):244-9. PubMed ID: 16341879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic interaction of the antiparasitic agents ivermectin and spinosad in dogs.
    Dunn ST; Hedges L; Sampson KE; Lai Y; Mahabir S; Balogh L; Locuson CW
    Drug Metab Dispos; 2011 May; 39(5):789-95. PubMed ID: 21321059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extra-label use of ivermectin in some minor ruminant species: pharmacokinetic aspects.
    González-Canga A; Belmar-Liberato R; Escribano M
    Curr Pharm Biotechnol; 2012 May; 13(6):924-35. PubMed ID: 22039789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of antiparasite treatment experiments in assessing the impact of parasites on wildlife.
    Pedersen AB; Fenton A
    Trends Parasitol; 2015 May; 31(5):200-11. PubMed ID: 25778845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy assessment of the albendazole-ivermectin combination in lambs parasitized with resistant nematodes.
    Entrocasso C; Alvarez L; Manazza J; Lifschitz A; Borda B; Virkel G; Mottier L; Lanusse C
    Vet Parasitol; 2008 Aug; 155(3-4):249-56. PubMed ID: 18571329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ivermectin exposure leads to up-regulation of detoxification genes in vitro and in vivo in mice.
    Albérich M; Ménez C; Sutra JF; Lespine A
    Eur J Pharmacol; 2014 Oct; 740():428-35. PubMed ID: 24998875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ivermectin, an antiparasitic agent.
    Campbell WC
    Med Res Rev; 1993 Jan; 13(1):61-79. PubMed ID: 8416263
    [No Abstract]   [Full Text] [Related]  

  • 13. The pharmacokinetics and interactions of ivermectin in humans--a mini-review.
    González Canga A; Sahagún Prieto AM; Diez Liébana MJ; Fernández Martínez N; Sierra Vega M; García Vieitez JJ
    AAPS J; 2008; 10(1):42-6. PubMed ID: 18446504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Field trial assessment of ivermectin pharmacokinetics and efficacy against susceptible and resistant nematode populations in cattle.
    Canton C; Canton L; Domínguez MP; Moreno L; Lanusse C; Alvarez L; Ceballos L
    Vet Parasitol; 2018 May; 256():43-49. PubMed ID: 29887029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Over 25 Years of Clinical Experience With Ivermectin: An Overview of Safety for an Increasing Number of Indications.
    Kircik LH; Del Rosso JQ; Layton AM; Schauber J
    J Drugs Dermatol; 2016 Mar; 15(3):325-32. PubMed ID: 26954318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic and persistent efficacy of a long-acting (LA) formulation of ivermectin against Rhipicephalus (Boophilus) microplus (Acari: Ixodidae) and sera concentration through time in treated cattle.
    Davey RB; Pound JM; Miller JA; Klavons JA
    Vet Parasitol; 2010 Apr; 169(1-2):149-56. PubMed ID: 20080349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next 'storm' could be parasiticide resistance.
    Vet Rec; 2019 Mar; 184(10):301. PubMed ID: 30846627
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiparasitic activity of ivermectin: Four decades of research into a "wonder drug".
    Sulik M; Antoszczak M; Huczyński A; Steverding D
    Eur J Med Chem; 2023 Dec; 261():115838. PubMed ID: 37793327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of ivermectin concentrations in target worms and host gastrointestinal tissues: influence of the route of administration on the activity against resistant Haemonchus contortus in lambs.
    Lloberas M; Alvarez L; Entrocasso C; Virkel G; Lanusse C; Lifschitz A
    Exp Parasitol; 2012 Jul; 131(3):304-9. PubMed ID: 22575734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of the parasiticide ivermectin on survival and reproduction of adult sepsid flies.
    Conforti S; Dietrich J; Kuhn T; Koppenhagen NV; Baur J; Rohner PT; Blanckenhorn WU; Schäfer MA
    Ecotoxicol Environ Saf; 2018 Nov; 163():215-222. PubMed ID: 30055386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.